Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 5 more interventions/treatments and noting that the study now has 26 locations, while the previous version v2.9.7 has been removed.
    Difference
    0.2%
    Check dated 2024-07-23T15:17:46.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T09:20:50.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-11T01:37:20.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-08T23:23:35.000Z thumbnail image
  9. Check
    21 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-05T18:11:42.000Z thumbnail image
  10. Check
    24 days ago
    Change Detected
    Summary
    The value Nivolumab Oxaliplatin has been changed to Oxaliplatin Nivolumab in the study details section of the webpage. This change represents an adjustment in the order of the drug names used in the study protocol.
    Difference
    0.1%
    Check dated 2024-07-03T16:13:28.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.